Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Ad26.Cov2.S"'
Autor:
Amelia Boehme, Raymond A. Harvey, Ann Madsen, Lexie Rubens, Astra Toyip, Michael Batech, Deborah Ricci, Mawuli Nyaku
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundThe goal of this FDA-committed, post authorization study was to assess the real-world effectiveness of Ad26.COV2.S in preventing observed COVID-19 disease in individuals in the United States interacting with the healthcare system who were v
Externí odkaz:
https://doaj.org/article/2eb9fa7baab448a5b8893eb413c976c3
Autor:
Veronica V. Rezelj, Fred Paddenburg, Marie Enajite Diegbe, Julius Nangosyah, Emil C. Reisinger, Weihong Hu, Carla Truyers, Gert Scheper, Mathieu Le Gars, Jenny Hendriks, Frank Struyf, Macaya Douoguih, Hanneke Schuitemaker, Javier Ruiz-Guiñazú
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1136 (2024)
Background: This study aimed to support the end-of-shelf life specification (2.5 × 1010 virus particles [vp]) for the standard Ad26.COV2.S dose (5 × 1010 vp). Methods: This randomized, double-blind Phase 3 study evaluated immunogenicity, reactogeni
Externí odkaz:
https://doaj.org/article/54705ff51339487aa084bce5e1e25b60
Autor:
Jennifer Serwanga, Laban Kato, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine, Isaac Kitabye, Angela Namuyanja, Solomon Opio, Joseph Ssebwana Katende, Peter Ejou, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe study investigation examined the immune response to the Janssen Ad26.COV2.S COVID-19 vaccine within a Ugandan cohort, specifically targeting antibodies directed against spike (S) and nucleocapsid (N) proteins. We aimed to examine the
Externí odkaz:
https://doaj.org/article/1db485c38c5a405ea296012ef5315fec
Autor:
Elizabeth-Barbara Tatsi, Filippos Filippatos, Thomas Bello, Vasiliki Syriopoulou, Athanasios Michos
Publikováno v:
Pathogens, Vol 13, Iss 4, p 284 (2024)
Sequencing of the T-cell repertoire is an innovative method to assess the cellular responses after immunization. The purpose of this study was to compare T-cell repertoires after COVID-19 immunization with homologous (HOB) and heterologous (HEB) boos
Externí odkaz:
https://doaj.org/article/54bad57b06804a528eb3c7b485cd46ab
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Platelets, Vol 33, Iss 5, Pp 797-800 (2022)
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare and life-threatening complication that can occur after COVID-19 vaccination. After the first reports of VITT and CVST in 2021 after Ad26.COV2.S vaccination, the FDA and CDC recommend
Externí odkaz:
https://doaj.org/article/7724078aad6a4b7298bdc63bf7bac2cf
Autor:
Maria Salsone, Carlo Signorelli, Alessandro Oldani, Valerio Fabio Alberti, Vincenza Castronovo, Salvatore Mazzitelli, Massimo Minerva, Luigi Ferini-Strambi
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1621 (2023)
Objective: In this Italian population-based study, we aimed to evaluate the neurological complications after the first and/or second dose of COVID-19 vaccines and factors potentially associated with these adverse effects. Methods: Our study included
Externí odkaz:
https://doaj.org/article/ca4be170787f46128235cf23ba3a6786
Autor:
Omar M. Albalawi, Maha I. Alomran, Ghada M. Alsagri, Turki A. Althunian, Thamir M. Alshammari
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 2, Pp 180-184 (2022)
Introduction: Since December 2020, three COVID-19 vaccines have been authorized in the United States (U.S.) and were proceeded by large immunization programs. The aim of this study was to characterize the U.S. post-marketing safety (PMS) profiles of
Externí odkaz:
https://doaj.org/article/d714547f932c4022be1a8e4a3d6478e5